The Journal of Pediatrics
Volume 157, Issue 3 , Pages 361-366 , September 2010

Oral Topiramate in Neonates with Hypoxic Ischemic Encephalopathy Treated with Hypothermia: A Safety Study

  • Luca Filippi, MD

      Affiliations

    • Neonatal Intensive Care Unit, Department of Critical Care Medicine, “A. Meyer” University Children's Hospital, Florence, Italy
    • Corresponding Author InformationReprint requests: Luca Filippi, MD, Neonatal Intensive Care Unit, Department of Critical Care Medicine, A. Meyer University Children's Hospital, Viale Pieraccini, 24 I-50139 Florence, Italy.
    • ,
  • Chiara Poggi, MD

      Affiliations

    • Neonatal Intensive Care Unit, Department of Critical Care Medicine, “A. Meyer” University Children's Hospital, Florence, Italy
    • ,
  • Giancarlo la Marca, Pharm Sc

      Affiliations

    • Department of Pharmacology, University of Florence, Florence, Italy
    • ,
  • Sandra Furlanetto, Pharm Sc

      Affiliations

    • Department of Pharmaceutical Sciences, University of Florence, Florence, Italy
    • ,
  • Patrizio Fiorini, MD

      Affiliations

    • Neonatal Intensive Care Unit, Department of Critical Care Medicine, “A. Meyer” University Children's Hospital, Florence, Italy
    • ,
  • Giacomo Cavallaro, MD

      Affiliations

    • Institute of Pediatrics and Neonatology, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, University of Milan, Milan, Italy
    • ,
  • Angela Plantulli, MD

      Affiliations

    • Neonatal Intensive Care Unit, “Carlo Poma” Hospital, Mantua, Italy
    • ,
  • Gianpaolo Donzelli, MD

      Affiliations

    • Department of Pediatrics, “A. Meyer” University Children's Hospital, Florence, Italy
    • ,
  • Renzo Guerrini, MD

      Affiliations

    • Department of Neurology and Neurosurgery, “A. Meyer” University Children's Hospital, Florence, Italy

Received 16 September 2009 ,Revised 26 March 2010 ,Accepted 9 April 2010.

References 

  1. Perlman JM. Summary proceedings from the neurology group on hypoxic-ischemic encephalopathy. Pediatrics. 2006;117:S28–S33
  2. Guerrini R, Parmeggiani L. Topiramate and its clinical applications in epilepsy. Expert Opin Pharmacother. 2006;7:811–823
  3. Shank RP, Gardocki JF, Streeter AJ, Maryanoff BE. An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia. 2000;41(Suppl. 1):S3–S9
  4. Costa C, Martella G, Picconi B, Prosperetti C, Pisani A, Di Filippo M, et al. Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia. Stroke. 2006;37:1319–1326
  5. Yang Y, Shuaib A, Li Q, Siddiqui MM. Neuroprotection by delayed administration of topiramate in a rat model of middle cerebral artery embolization. Brain Res. 1998;804:169–176
  6. Lee SR, Kim SP, Kim JE. Protective effect of topiramate against hippocampal neuronal damage after global ischemia in the gerbils. Neurosci Lett. 2000;281:183–186
  7. Edmonds HL, Jiang YD, Zhang PY, Shank R. Topiramate as a neuroprotectant in a rat model of global ischemia-induced neurodegeneration. Life Sci. 2001;69:2265–2277
  8. Schubert S, Brandl U, Brodhun M, Ulrich C, Spaltmann J, Fiedler N, et al. Neuroprotective effects of topiramate after hypoxia-ischemia in newborn piglets. Brain Res. 2005;1058:129–136
  9. Liu Y, Barks JD, Xu G, Silverstein FS. Topiramate extends the therapeutic window for hypothermia-mediated neuroprotection after stroke in neonatal rats. Stroke. 2004;35:1460–1465
  10. Noh MR, Kim SK, Sun W, Park SK, Choi HC, Lim JH, et al. Neuroprotective effect of topiramate on hypoxic ischemic brain injury in neonatal rats. Exp Neurol. 2006;201:470–478
  11. Follett PL, Deng W, Dai W, Talos DM, Massillon LJ, Rosenberg PA, et al. Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. J Neurosci. 2004;24:4412–4420
  12. Choi JW, Kim WK. Is topiramate a potential therapeutic agent for cerebral hypoxic/ischemic injury?. Exp Neurol. 2007;203:5–7
  13. Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet. 2005;365:663–670
  14. Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med. 2005;353:1574–1584
  15. Eicher DJ, Wagner CL, Katikaneni LP, Hulsey TC, Bass WT, Kaufman DA, et al. Moderate hypothermia in neonatal encephalopathy: efficacy outcomes. Pediatr Neurol. 2005;32:11–17
  16. Compagnoni G, Bottura C, Cavallaro G, Cristofori G, Lista G, Mosca F. Safety of deep hypothermia in treating neonatal asphyxia. Neonatology. 2008;93:230–235
  17. Tortorici MA, Kochanek PM, Poloyac SM. Effects of hypothermia on drug disposition, metabolism, and response: A focus of hypothermia-mediated alterations on the cytochrome P450 enzyme system. Crit Care Med. 2007;35:2196–2204
  18. Filippi L, la Marca G, Fiorini P, Poggi C, Cavallaro G, Malvagia S, et al. Topiramate concentrations in neonates treated with prolonged whole body hypothermia for hypoxic ischaemic encephalopathy. Epilepsia. 2009;50:2355–2361
  19. Kudin AP, Debska-Vielhaber G, Vielhaber S, Elger CE, Kunz WS. The mechanism of neuroprotection by topiramate in an animal model of epilepsy. Epilepsia. 2004;45:1478–1487
  20. Filippi L, Messeri A, Dani C, Pezzati M, Tronchin M, Giani T, et al. Redox status in very-low birth-weight newborns. Biol Neonate. 2004;85:210–216
  21. Rutherford MA, Azzopardi D, Whitelaw A, Cowan F, Renowden S, Edwards AD, et al. Mild hypothermia and the distribution of cerebral lesions in neonates with hypoxic-ischemic encephalopathy. Pediatrics. 2005;116:1001–1006
  22. Kruskal WH, Wallis WA. Use of ranks in one-criterion variance analysis. J Am Stat Assoc. 1952;47:583–621
  23. Glantz SA. Primer of biostatistics. 6th ed.. New York: McGraw-Hill; 2005;
  24. Glantz SA. Statistical software program. Version 6.0. New York: McGraw-Hill; 2005;
  25. Robertson CM, Finer NN, Grace MG. School performance of survivors of neonatal encephalopathy associated with birth asphyxia at term. J Pediatr. 1989;114:753–760
  26. Shankaran S, Woldt E, Koepke T, Bedard MP, Nandyal R. Acute neonatal morbidity and long-term central nervous system sequelae of perinatal asphyxia in term infants. Early Hum Dev. 1991;25:135–148
  27. Angehagen M, Rönnbäck L, Hansson E, Ben-Menachem E. Topiramate reduces AMPA-induced Ca(2+) transients and inhibits GluR1 subunit phosphorylation in astrocytes from primary cultures. J Neurochem. 2005;94:1124–1130
  28. Sfaello I, Baud O, Arzimanoglou A, Gressens P. Topiramate prevents excitotoxic damage in the newborn rodent brain. Neurobiol Dis. 2005;20:837–848
  29. Kaminski RM, Banerjee M, Rogawski MA. Topiramate selectively protects against seizures induced by ATPA, a GluR5 kainate receptor agonist. Neuropharmacology. 2004;46:1097–1104
  30. Koh S, Tibayan FD, Simpson JN, Jensen FE. NBQX or topiramate treatment after perinatal hypoxia-induced seizures prevents later increases in seizure-induced neuronal injury. Epilepsia. 2004;45:569–575
  31. Zona C, Ciotti MT, Avoli M. Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells. Neurosci Lett. 1997;231:123–126
  32. Dodgson SJ, Shank RP, Maryanoff BE. Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia. 2000;41(Suppl. 1):S35–S39
  33. Zhao H, Asai S, Kanematsu K, Kunimatsu T, Kohno T, Ishikawa K. Real-time monitoring of the effects of normothermia and hypothermia on extracellular glutamate re-uptake in the rat following global brain ischemia. Neuroreport. 1997;8:2389–2393
  34. Koren G, Barker C, Bohn D, Kent G, Biggar WD. Influence of hypothermia on the pharmacokinetics of gentamicin and theophylline in piglets. Crit Care Med. 1985;13:844–847
  35. Walia KS, Khan EA, Ko DH, Raza SS, Khan YN. Side effects of antiepileptics-a review. Pain Pract. 2004;4:194–203
  36. Garris SS, Oles KS. Impact of topiramate on serum bicarbonate concentrations in adults. Ann Pharmacother. 2005;39:424–426
  37. Philippi H, Boor R, Reitter B. Topiramate and metabolic acidosis in infants and toddlers. Epilepsia. 2002;43:744–747
  38. Asconape JJ. Some common issues in the use of antiepileptic drugs. Semin Neurol. 2002;22:27–39
  39. Filippi L, Bagnoli F, Margollicci M, Zammarchi E, Tronchin M, Rubaltelli FF. Pathogenic mechanism, prophylaxis, and therapy of symptomatic acidosis induced by acetazolamide. J Investig Med. 2002;50:125–132
  40. Wirrell EC. Neonatal seizures: to treat or not to treat?. Semin Pediatr Neurol. 2005;12:97–105
  41. Fanaroff JM, Fanaroff AA. Blood pressure disorders in the neonate: hypotension and hypertension. Semin Fetal Neonatal Med. 2006;11:174–181
  42. Silverstein FS, Ferriero DM. Off-label use of antiepileptic drugs for the treatment of neonatal seizures. Pediatr Neurol. 2008;39:77–79
  43. Glier C, Dzietko M, Bittigau P, Jarosz B, Korobowicz E, Ikonomidou C. Therapeutic doses of topiramate are not toxic to the developing rat brain. Exp Neurol. 2004;187:403–409
  44. The CRIB (Clinical Risk Index for Babies) score: a tool for assessing initial neonatal risk and comparing performance of neonatal intensive care units. The International Neonatal Network. Lancet. 1993;342:193–198

 The authors declare no conflicts of interest.

PII: S0022-3476(10)00319-7

doi: 10.1016/j.jpeds.2010.04.019

The Journal of Pediatrics
Volume 157, Issue 3 , Pages 361-366 , September 2010

Article Tools

* Image Usage & Resolution